FDA Inspection
Imaging Endpoints II, LLC.Imaging Endpoints II, LLC. – FDA Inspection, Feb 12, 2021
Record Details
This FDA Inspection record concerns Imaging Endpoints II, LLC., with an inspection on February 12, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Imaging Endpoints II, LLC.
- Inspection Date
- February 12, 2021
- Product Type
- Drugs
View Company Profile
ID · 7a480232-0806-4ba9-9ae9-775e2b4a79d4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1136122
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Imaging Endpoints II, LLC.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2026 | Not classified | Denver District Office | |
| April 4, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 25, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 7, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Imaging Endpoints II, LLC.
- FDA Inspection 1309166 - 2026-03-12
- FDA Inspection 1266886 - 2025-04-04
- FDA Inspection 1222597 - 2023-10-25
- FDA Inspection 1056608 - 2018-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.